Montauk Flips the Switch in North Carolina

A debt-funded pivot to swine-waste power starts producing — and RIN stability finally gives the tape something to hold.

MNTK · Earnings Call · 2026-08-06

Montauk Renewables' last two years have been a study in patience-capital punishment: the shares fell 90.7% from their September 2022 peak, as a microcap (just ~$209M today) specialty-chemicals / landfill-gas operator kept spending and kept deferring its payoff. The bet was always Turkey — a swine-waste conversion facility in North Carolina, financed largely through the balance sheet. On the Q2 2026 call, the inflection point finally arrived:

In July 2026, we began generating power for sale from our Turkey, North Carolina facility. This production of power is expected to be eligible to generate both swine RECs and enhanced RECs in subsequent months.
Sean McClain, Chief Executive Officer · 2026-08-06

That single sentence reframes the entire bear case. The project — with hog spaces contracted across more than 50 farms, over 250,000 of a 400,000–450,000 target actively collecting feedstock — is no longer a capex sink. Management held the line on the $200M first-phase budget, expects the switch-gear programming complete by mid-August to "consistently generate power and RECs from all available collected feedstock volumes," and is already negotiating additional North Carolina REC offtake beyond the existing Duke contract. The swine REC opportunity was among the biggest keyword spikes in this company's history (230 momentum in Q4 2024) — and now it is a revenue line, not a plan. The company's own keyword history captures the swing: "Turkey" touched 230 momentum in early 2025, then fell out of favor as commissioning slipped a month; in May, Kevin Van Asdalan conceded the revenue guidance shift was “solely attributed to the timing of the commissioning that was completed at the end of April” — Sean McClain, President and Chief Executive Officer · 2026-05-07. That excuse is gone, and the financials confirm it: Q2 operating loss narrowed to just $75,000, and net income flipped from a -$5.5M loss to +$0.2M. EBITDA swung even harder, up 151% to $11.7M, on the back of the new production.

The RIN Overhang Defuses

The second pillar of the old bear case was RIN price fragility — MNTK self-markets a majority of its D3 RINs, so a soft compliance market hits revenue directly. Here the news is quietly constructive. The company has committed the majority of its expected Q3 2026 RNG production at an average RIN of “$2.66” — Kevin Van Asdalan, Chief Financial Officer · 2026-08-06, versus a July D3 index of $2.64 — proactive forward sales done at a premium to spot. On the Q&A, Kevin attributed the stability to the market clearing the 2025 vintage overhang (“we think some of that stability was coming through – there was an extended year settlement for 2025 that completed itself in the second quarter” — Kevin Van Asdalan, Chief Financial Officer · 2026-08-06), while Sean pointed to a structural shift in buyer behavior: “I do see an increase in the predominance of those obligated parties stepping into the marketplace and buy more regularly earlier on in the compliance year than we've seen in previous years” — Sean McClain, Chief Executive Officer · 2026-08-06. That is the obligated party dynamic finally maturing — a theme recurring across this company's keyword stream for years — now backed by hard forward-price evidence instead of hopes.

GreenWave: A New Capital-Light Revenue Line

Beyond the core ramp, the GreenWave joint venture added a genuinely new monetization mechanism. The JV matches third-party RNG volumes to proprietary transportation pathways and distributes separated RINs back to partners. In Q2, Montauk received ~1.5 million separated RINs and sold ~1.9 million, booking ~$4.8M of revenue, with ~$8.3M of associated RIN/pathway costs inside opex. That's attribute brokerage that scales without tying up balance sheet — and it's already moving the P&L: adjusted EBITDA rose 144.5% to $12.3M, the strongest step in years. The mix shift is unmistakable: RINs sold rose 29.1% at a 1.2% higher average price, while fixed-price RNG commodity revenue fell ~64% as legacy contracts rolled off — exactly the pivot to self-marketed attribute sales management flagged last quarter (“It's in concert with a quarter-over-quarter reduction in RINs that we're sharing with counterparties through our pathway” — Kevin Van Asdalan, CFO or Financial Officer (inferred from discussing financial results) · 2026-05-07).

What's Priced In — and What Isn't

The tape has already priced a good chunk of the good news: +57% over the trailing 90 days, the name's best run since 2022. But that comes off a brutal base — the stock still sits ~84% below its peaks, and P/S has fallen to about 0.9x. The balance sheet is the offsetting bookend: effective net cash is -$121M, and liabilities-to-assets jumped ~17pp year-over-year with $155M drawn under the new HASI credit agreement. Montauk remains in compliance with those covenants, but this is a debt-funded inflection, and free cash flow is still deeply negative while capex runs hot ($61M in the first half, with $17M more in payables). The market-level keyword "commercial readiness" ranks #4 in the current global quarter — that's exactly the pivot MNTK is executing, from development into operations. The setup is classic asymmetric: a microcap, off 90%, that has just crossed its operational threshold and is being paid for it. Sean's August 2025 framing holds: “The North Carolina project that we are developing is definitively one of the most exciting projects that we have designed and constructed to date.” — Sean McClain, President and Chief Executive Officer · 2025-05-09 Now the electrons are flowing — and so is the RIN revenue.